Biohit Oyj — Director's Dealing 2017

Mar 1, 2017

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 1, 2017 at 4:35 pm local time (EET)

Person subject to the notification requirement
Name: Interlab Oy Legal Person
Position: Closely associated person

Person discharging managerial responsibilities in issuer
Name: Suovaniemi, Osmo
Position: Member of the Board/Deputy member

---

Initial Notification
Reference number: 74370089ATTSNBXJVT29_20170301161015_1

---

Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29

---

Transaction details
Transaction date: 2017-02-22
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Lending
Further details:
Linked to stock option programme

Instrument: Share
ISIN: FI0009005482

Volume: 130000
Unit price: 0,00000 Not Applicable

Aggregated transactions
Volume: 130000
Volume weighted average price: 0.00000 Not Applicable

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com